Ipsen

Ipsen is a mid-sized global biopharmaceutical company with a strong focus on developing innovative medicines in three key therapeutic areas: oncology, rare disease, and neuroscience. The company is committed to improving patients' lives and health outcomes by prioritizing development in areas of high unmet medical need. With over 90 years of experience, Ipsen has a proven track record in research, innovation, and the commercialization of its medicines, demonstrated through its presence in 88 countries and a robust pipeline of potential treatments.

Ipsen differentiates itself from other large pharmaceutical companies by its commitment to a collaborative culture, a focus on speed and agility, and a commitment to "Focus. Together. For patients and society." The company actively seeks external innovation through partnerships and acquisitions, and actively invests in research and development with a dedication to bringing new treatments to patients who need them most. Its commitment to sustainability is embodied in the "Generation Ipsen" ESG responsibility strategy, which sets ambitious goals for the company in each of its four pillars: Environment, Patients, People, and Governance.

Ipsen offers employees flexible work arrangements that cater to individual needs and circumstances, promoting a healthy work-life balance. They offer schemes that adapt to different situations, provide great health and well-being benefits, and encourage a positive work environment that includes sports facilities, social activities, and employee services in key locations.

Ipsen provides a comprehensive package of employee benefits, prioritizing employee well-being and recognizing their contributions. They offer competitive compensation packages, a recognition program, and opportunities for sharing in the company's success. Ipsen also emphasizes work-life balance with flexible schemes and provides benefits for health and well-being, including access to sports facilities and social activities in key locations. Additionally, they offer a comprehensive learning and development program based on the 70/20/10 model, including training and coaching, to empower employees to own their growth and achieve their career goals.

Ipsen is a global biopharmaceutical company committed to improving the lives of patients with serious or rare diseases. Focused on three key therapeutic areas - oncology, rare disease, and neuroscience - Ipsen aims to develop and deliver innovative medicines that address unmet medical needs and create a positive impact for both patients and society.

Ipsen promotes a culture of collaboration and excellence, emphasizing a shared purpose of improving patients' lives. The company values leadership with purpose, learning and sharing, driving for success, trusting each other, and owning outcomes, fostering an inclusive and diverse environment where employees can make a real impact.

Ipsen is committed to building a diverse and inclusive workforce and has implemented a variety of initiatives to achieve this goal. The company recognizes the importance of diversity and equity in creating a welcoming and challenging workplace, and has been recognized as a Great Place to Work® in 18 locations worldwide. They strive to embed diversity, equity and inclusion (DE&I) principles into their talent acquisition process, focusing on equitable outcomes in their recruitment and onboarding phases.